Ganirelix Acetate Injection
Product Images NDC 70700-327

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ganirelix Acetate (NDC 70700-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ganirelix-spl-carton-label (Ganirelix Spl Carton Label)

Ganirelix-spl-carton-label (Ganirelix Spl Carton Label)
This is a description of a Ganirelix Acetate Injection product in a 250 mcg/0.5 mL dosage form for subcutaneous use. The product is contained in a single-dose, sterile, prefilled syringe with a 27-gauge needle. The syringe contains 0.5 mL of ganirelix acetate, glacial acetic acid, mannitol, and water for injection adjusted to pH 5.0. The prescribing information should be consulted for dosage instructions, and any unused portion should be discarded. The product should be stored at 20° to 25°C and protected from light. The packaging components are latex-free. This product is manufactured for Coda N TSDRUGS by Xiromed, LLC in Florham Park, NJ, and is a product of India.*
FDA Label Image

Ganirelix-spl-container-label (Ganirelix Spl Container Label)

Ganirelix-spl-container-label (Ganirelix Spl Container Label)
This is a description of a Ganirelix Acetate Injection pre-filled syringe with a 127 gauge 1/2" needle. Each syringe contains 250 mcg/0.5 mL of the medication for subcutaneous use. The product is manufactured for Xiromed, LLC in Florham Park, NJ, and it is a product of India. The syringe is for single-dose sterile use and should be discarded if unused. It is important to protect the medication from light. The NDC code for this product is 70700-327-98. The expiration date is February 2024.*
FDA Label Image

Ganirelix-spl-structural-formula (Ganirelix Spl Structural Formula)

FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.